⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
TIMP2–ECM–Microglia Axis in Brain Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-11 — Dendritic Cell Antigen Presentation Enables T Cells to Enter the Brain and Contribute to Tau Pathology: cross-connection with immunosenescence: Adaptive-immune infiltration is proposed to act alongside microglial inflammation in tauopathy, connecting immunosenescence directly to CNS microglial-state biology. (novelty: 3)
- 2026-06-03 — Senolytics ameliorate cognitive decline in D-galactose-induced aging mice by inhibiting astrocytic cholesterol accumulation.: cross-connection with cellular-senescence: Two independent 2026 preclinical lines now nominate glial cells (astrocytes via cholesterol biosynthesis; microglia via TIMP2/ECM) as CNS senescence/inflammation nodes rescuable by senolytic or youth-associated protein interventions, converging on glia as a shared substrate for cognitive-aging modulation. (novelty: 3)
- 2026-08-12 — Youth-associated protein TIMP2 regulates microglial state and function in healthy and aged mice.: 2026 mouse study (healthy + aged): TIMP2 knockout worsens microglial transcriptomic activation, elevates CD68/lysosomal markers, and disrupts myelin and physiological-substrate phagocytosis, while systemic TIMP2 administration to aged mice reverses several of these phenotypes and reduces extracellular inflammatory stress — bidirectional loss/gain-of-function evidence extending the TIMP2 youth-factor story from ECM/synaptic biology into microglial state regulation. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Youth-associated protein TIMP2 regulates microglial state and function in healthy and aged mice.
12-aug-2026
novelty 3
per-area 3
strengthens